CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The IMMUTRAIN project focuses on training researchers in immunotherapy, specifically in antibody-based treatments for cancer. It connects academic and industrial experts to enhance skills in developing combinatorial therapies and bispecific antibodies, aiming to improve cancer care outcomes.
In the European Union, cancer is the leading cause of death and the overall cancer incidence is still increasing.
As a result of expanding efforts to improve cancer outcome, a main paradigm change is occurring in cancer therapy towards individualized medicine.
Antibody-based therapies form an integral and constantly growing part of this approach.
Antibody-based therapies will strongly influence the coming decade of cancer care.
The importance of immunotherapy has been highlighted by the prestigi…
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
STICHTING RADBOUD UNIVERSITEIT
Netherlands, Nijmegen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Mannheim
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
United Kingdom, Nottingham
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Italy, Milano
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
